Replies to post #182685 on Biotech Values

[willyw]

Thanks, I was looking for that earlier and gave up.
Now I will give it a read. I didn't post my opinion cause I figured it wasn't worth much.

My sense on the earlier Sovaldi approval last year was that it was a little early, and that this form of treatment is so much cleaner and safer, easier, superior. I thought it might get an earlier approval for that reason alone. If I recall, nearly 8-10K die per year from liver disease in the USA due to HCV.

Anyway, yes, we will see about the Abbvie 3D approval. I've no reason to doubt the members here are wrong. I would like it approved sooner. When the FDA does is yet another question. : )
Before thanksgiving would be great!